{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "332",
                "340"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Metocard"
        },
        {
            "identifier": "T2",
            "position": [
                "341",
                "350"
            ],
            "subtype": "Drug_dose",
            "type": "T",
            "value": "1 x 50 mg"
        },
        {
            "identifier": "T3",
            "position": [
                "353",
                "387"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "kontrola w Poradni Kardiologicznej"
        },
        {
            "identifier": "T4",
            "position": [
                "388",
                "397"
            ],
            "subtype": "Date",
            "type": "T",
            "value": "za 3 m-ce"
        },
        {
            "identifier": "T5",
            "position": [
                "615",
                "660"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Zaburzenia rytmu serca pochodzenia komorowego"
        },
        {
            "identifier": "T6",
            "position": [
                "800",
                "819"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wrodzon\u0105 wad\u0105 serca"
        },
        {},
        {
            "identifier": "T7",
            "position": [
                "897",
                "907"
            ],
            "subtype": "Symptom",
            "type": "T",
            "value": "Stan dobry"
        },
        {
            "icd": "ICD10:I49.9",
            "identifier": "N1",
            "referenced": "T5",
            "subtype": "Reference",
            "type": "N",
            "value": "Zaburzenia rytmu serca, nieokre\u00c5\u009blone"
        },
        {
            "icd": "ICD10:Q20",
            "identifier": "N2",
            "referenced": "T6",
            "subtype": "Reference",
            "type": "N",
            "value": "Wrodzone wady rozwojowe jam i po\u00c5\u0082\u00c4\u0085cze\u00c5\u0084 sercowych"
        },
        {
            "arg1": "T1",
            "arg2": "T2",
            "identifier": "R1",
            "subtype": "Drg",
            "type": "R"
        },
        {
            "arg1": "T4",
            "arg2": "T3",
            "identifier": "R2",
            "subtype": "Dat",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 11 lat\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nZalecenia\n------------------------------------------------\n- Metocard 1 x 50 mg\n- kontrola w Poradni Kardiologicznej za 3 m-ce\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Zaburzenia rytmu serca pochodzenia komorowego.\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nDziewczynka z wrodzon\u0105 wad\u0105 serca  przyj\u0119ta do Kliniki do poszerzonych bada\u0144 i ustalenia dalszego post\u0119powania Stan dobry\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:6.68[10\\\\^3/ul]\n    RBC:4.74[10\\\\^6/ul]\n    HGB:13.6[g/dl]\n    HCT:38.1[%]\n    MCV:80.4[fl]\n    MCH:28.7[pg]\n    MCHC:35.7[g/dl]\n    PLT:224.0[10\\\\^3/ul]\n    RDW-SD:37.5[fl]\n    RDW-CV:13.0[%]\n    PDW:14.7[fl]\n    MPV:11.9[fl]\n    P-LCR:39.5[%]\n    PCT:0.3[%]\n    NEUTR#:2.32[10\\\\^3/ul]\n    NEUTR%:34.9[%]\n    LYMPH#:3.41[10\\\\^3/ul]\n    LYMPH%:51.0[%]\n    MONO#:0.67[10\\\\^3/ul]\n    MONO%:10.00[%]\n    EO#:0.25[10\\\\^3/ul]\n    EO%:3.70[%]\n    BASO#:0.03[10\\\\^3/ul]\n    BASO%:0.40[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nBadanie - Elementy  moczu niewirowanego\n    Erym:5 /uL\u015bw.[ul]\n    Leum:12 /uL[ul]\n    Bakm:nieliczne[wpw]\n    KrysztSzcz:liczne[wpw]\n    NabP\u0142m:bardzo liczne[wpw]\n    Pas\u015al:dosc liczny[wpw]\nBadanie og\u00f3lne moczu\n    Barwa:\u017c\u00f3\u0142ta\n    Przej:niezupe\u0142na\n    SG:1.023\n    pH:5.0\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cona\n    BIL:nieobecna\n    ERY:nieobecna[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nFibrynogen (F): FIB:2.30[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:32.3[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:12.1[s]\nKwas mlekowy: LAC:21.20[mg/dl]\nKwas mlekowy: LAC:66.50[mg/dl]\nCK - kinaza kreatynowa: CK:55.00[IU/L]\nLDH dehydrogenaza mleczanowa: LDH:473.00[IU/L]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:91[%]\nKreatynina: CREA:0.60[mg/dl]\nMocznik: UREA:23.00[mg/dl]\nASPAT: AST:19.00[IU/L]\nALAT: ALT:24.00[IU/L]\nNT- proBNP: NTpBNP:114.00[pg/ml]\nCK-MB aktywno\u015b\u0107: CK-MBakt.:12.00[IU/L]\neGFR zmod. wg Schwartza wsp. 0.413: eGFRzmod:103.3[ml/min/1,73m2]\nWzrost pacjenta: WzrostPac:150[cm]\neGFR (1-13r\u017c M) stand.wg.Schwartza  wsp. 0.550: eGFR 1-13M:137.5[ml/min/1,73m2]\n------------------------------------------------\nICD10\n------------------------------------------------\nI49.2\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.43\nG21\n89.541\n------------------------------------------------"
}